Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Science convergence applied to psychoneuroimmunology: the future of measurement and imaging|
|Citation:||Brain, Behavior, and Immunity, 2020; 88:262-269|
|Mark R Hutchinson|
|Abstract:||The future of psychoneuroimmunology requires breakthrough technology discoveries. These next generation technologies need to address the unique challenges that are raised by imaging and measuring the activity of the neuroimmune interface in health and disease. The complexity of this challenge is centred around the multidimensionality of the neuroimmune system. These include novel challenges of capturing potent and rare biological signals over long times and vast anatomical distances. Here is a summary of the outcomes of the investments made by the Australian Research Council Centre of Excellence for Nanoscale BioPhotonics which was presented as part of the PNIRSAsia-Pacific symposium at the 2019 International Brain Research Organization.|
|Keywords:||Glia; technology; laser; microscopy; nanoparticle; disease; brain|
|Rights:||© 2020 Elsevier Inc. All rights reserved.|
|Appears in Collections:||Medicine publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.